Expert Consensus on Tumor Mutational Burden for Immunotherapy in Lung Cancer

Lung cancer is one of the malignant tumors with the highest morbidity and mortality in the world. Immune checkpoint inhibitors (ICIs), including programmed cell death 1 (PD-1) antibody, programmed cell death ligand 1 (PD-L1) antibody, and cytotoxic T lymphocyte associated protein 4 (CTLA-4) antibody...

Full description

Saved in:
Bibliographic Details
Main Authors: Chinese Society of Clinical Oncology, Expert Committee on Tumor Vascular-targeted Therapy, Chinese Society of Clinical Oncology, Expert Committee on Non-small Cell Lung Cancer
Format: article
Language:ZH
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2021
Subjects:
Online Access:https://doaj.org/article/73efbbca7aad481c9495e49e699bda8c
Tags: Add Tag
No Tags, Be the first to tag this record!